“I got very interested in trying to understand what the mechanisms are for how Rapamycin was affecting the biological aging process.”
Main Takeaways:
- Rapamycin has been studied across various species for its effects on aging.
- It consistently shows positive results in preclinical studies.
- Rapamycin impacts both longevity and health span in complex animals.
Notes: Introduction to the topic of Rapamycin and its study across species.
Tone: Enthusiastic
Relevance: 5/5
“I've worked on Rapamycin my entire scientific career going back to my PhD.”
Main Takeaways:
- David has extensive experience researching Rapamycin.
- His work includes understanding the biochemical mechanisms of mTOR, which Rapamycin affects.
Notes: David provides a background on his long-term research focus on Rapamycin.
Tone: Proud
Relevance: 5/5
“We were really interested in understanding what are the genetics that control longevity and so we did an unbiased search for new genes that would affect lifespan and happened to find mTOR.”
Main Takeaways:
- Matt's research initially focused on genetics of longevity leading to the discovery of mTOR's role.
- mTOR is a significant genetic factor in controlling lifespan.
Notes: Matt explains how his research led to discovering the role of mTOR in longevity.
Tone: Informative
Relevance: 5/5
“I immediately went and looked up everything I could learn about mtor and found out there's this drug rapy that's an inhibitor of mtor and then we found that we could also increase lifespan with rapy and at this point we were working in yeast but then it became clear to me because of the work of others that this pathway and this drug appeared to affect the biological aging process not only in yeast but also across the animal kingdom.”
Main Takeaways:
- Rapamycin is an inhibitor of the mTOR pathway.
- Research initially in yeast showed that rapamycin could increase lifespan.
- Further studies indicated that rapamycin affects the biological aging process across various species.
Notes: Speaker discussing initial research findings on rapamycin.
Tone: enthusiastic
Relevance: 5/5
“I think through all of that the one thing that that has kind of kept me excited about Ramy as a potential longevity therapeutic is that it always works and I would say without question it is the most robust and reproducible drug at least from pre-clinical studies that we know about today for impacting not only longevity but to the extent that we can measure various metrics of Health span.”
Main Takeaways:
- Rapamycin consistently shows positive results in pre-clinical studies for longevity and health span.
- It is considered robust and reproducible in its effects on aging.
Notes: Speaker emphasizing the consistent effectiveness of rapamycin in research.
Tone: enthusiastic
Relevance: 5/5
“We are actually carrying out a Veterinary clinical trial of ramyon in pet dogs right now we've got some preliminary data but it's too early to be able to say you know with any level of confidence that Romy is going to positively impact the aging process in dogs but I think we've already learned a lot about safety and maybe some hints about efficacy.”
Main Takeaways:
- A veterinary clinical trial of rapamycin in pet dogs is currently underway.
- Preliminary data is available but conclusive results on its efficacy in aging are not yet determined.
- Initial findings suggest information on safety and potential efficacy.
Notes: Discussion of ongoing research involving rapamycin in dogs.
Tone: cautious
Relevance: 4/5
“the discovery of rapamycin is the place to begin this because you know there's a very unique phenomenon here which is the drug was discovered before the Target and the target is named after the drug in response to that.”
Main Takeaways:
- Rapamycin was discovered before its biological target was identified.
- The target of rapamycin was named after the drug itself.
Notes: Discussion on the unique discovery process of rapamycin.
Tone: Informative
Relevance: 4/5
“Rapamycin and other mTOR inhibitors for other uses because it was developed clinically as an organ transplant immunosuppressant and that's how it was first approved.”
Main Takeaways:
- Rapamycin was initially developed and approved as an immunosuppressant for organ transplants.
- The clinical development path of rapamycin may have negatively impacted its testing for other potential uses.
Notes: Discussion on the clinical development and potential broader applications of rapamycin.
Tone: Cautious
Relevance: 4/5
“the first paper that seren seal put out there describing the chemical composition of rapamycin was about 1971 1972 the FDA approval for Rapamycin in humans was 1999”
Main Takeaways:
- Rapamycin was first described in a paper around 1971-1972.
- FDA approved Rapamycin for human use in 1999.
Notes: Discussing the timeline of Rapamycin development and approval.
Tone: Informative
Relevance: 4/5
“we were giving Rapamycin out constantly and to your point Matt it was a drug that was typically given 2 to 3 milligrams a day every single day but with three other drugs right you were also getting prednisone, cellep, MMF you were getting very very toxic drugs because you needed to completely shut down the cellular immune system of a patient who had just received a foreign organ”
Main Takeaways:
- Rapamycin was administered daily at 2 to 3 milligrams along with other drugs like prednisone, cellep, and MMF.
- These drugs were used in combination to suppress the immune system in transplant patients.
Notes: Describing the clinical use of Rapamycin in transplant patients.
Tone: Clinical
Relevance: 5/5
“once we started making that connection of rapamycin into nutrients right which which many groups did uh if you actually look at the history of it and and it was already appreciated for many many decades before that things like caloric restriction had an impact on lifespan”
Main Takeaways:
- Research groups have linked rapamycin with nutrient sensing pathways.
- Historically, caloric restriction has been known to impact lifespan.
Notes: Discussing the connection between rapamycin and nutrient sensing in relation to lifespan.
Tone: Exploratory
Relevance: 4/5
“with rapamycin it's not only the drug but we also have genetic inhibition of mtor in each of those model systems that recapitulates the longevity and health span benefits”
Main Takeaways:
- Rapamycin affects longevity not only as a drug but also through genetic pathways.
- Genetic inhibition of mTOR in model systems shows similar longevity and health span benefits.
- This suggests a strong link between mTOR pathways and longevity.
Notes: Speaker is adding context to another expert's statement on rapamycin.
Tone: Informative
Relevance: 5/5
“if we looked at all of the genes at that time that were known to affect lifespan in yeast and all of the genes that were known to affect lifespan in worms and we simply looked at orthologues meaning the same gene in each organism how often is genetic control of longevity shared and it turns out it's pretty often”
Main Takeaways:
- Research has explored genes affecting lifespan in yeast and worms, focusing on orthologues.
- There is a high degree of genetic control of longevity shared across these species.
- This suggests evolutionary conservation in genetic factors influencing longevity.
Notes: Speaker is discussing a study on genetic control of longevity across species.
Tone: Explanatory
Relevance: 5/5
“the genetics of longevity are conserved not everything's going to be conserved but it has been statistically shown that there is a conservation of the biology of aging”
Main Takeaways:
- Genetic factors related to longevity show a significant level of conservation across different organisms.
- This conservation supports the use of model organisms to study human aging.
- Statistical evidence supports the conservation of aging biology.
Notes: Speaker is addressing misconceptions about the relevance of model organisms in aging research.
Tone: Clarifying
Relevance: 5/5
“David said at the outset right which is mtor is the master regulator of how nutrients trickle into the system are you going to be in an anabolic state or are you going to be in a catabolic State.”
Main Takeaways:
- MTOR regulates nutrient processing and determines whether the body is in an anabolic (building up) or catabolic (breaking down) state.
- Understanding MTOR's role is crucial for manipulating metabolic states for health benefits.
Notes: Discussion on the role of MTOR in nutrient regulation.
Tone: Informative
Relevance: 4/5
“it was very fortunate in this case that it happened the way that that it did but we I would argue as a research Enterprise should develop an appetite for higher risk higher reward projects.”
Main Takeaways:
- The accidental discovery in the study highlights the importance of embracing high-risk, high-reward research in biomedicine.
- Encourages a shift in research funding priorities to support potentially groundbreaking studies.
Notes: Reflecting on the serendipitous nature of scientific discoveries and funding strategies.
Tone: Reflective
Relevance: 3/5
“there are a bunch of those kinds of fundamental questions that I would argue are relatively lwh hanging fruit that that and then we would have to think about prioritizing right so we made I think we're going to talk a little bit about rapalogs or other classes of mtor Inhibitors”
Main Takeaways:
- Discussion on prioritizing research on rapalogs and other mTOR inhibitors.
- mTOR inhibitors are considered important for their potential effects on aging and disease.
- Funding for such studies is challenging.
Notes: Discussion on research priorities and funding challenges.
Tone: Analytical
Relevance: 4/5
“there was just recently the first study that I know of that tested a uh ATP competitive mtor inhibitor in mice and it's intriguing I would say early data but we really have no clue as far as I can tell how other classes of mtor Inhibitors would perform relative to rap ayon”
Main Takeaways:
- Recent study tested an ATP-competitive mTOR inhibitor in mice.
- Results are preliminary and it's unclear how this class compares to others like rapamycin.
- Highlights the need for more comparative studies among mTOR inhibitors.
Notes: Discussion on the need for more research on mTOR inhibitors.
Tone: Cautious
Relevance: 4/5
“I think it's also important to understand how nutrients work right so we're going to talk a lot about amino acids and probably in particular Lucine”
Main Takeaways:
- Emphasis on understanding how nutrients, specifically amino acids, function in the body.
- Lucine is highlighted as a particularly important amino acid.
- Understanding nutrients is crucial for comprehending broader biological processes.
Notes: Introduction to a discussion on the biochemical roles of nutrients.
Tone: Informative
Relevance: 5/5
“there's actually genetics on Raptor that connect it to to lifespan in the aging process”
Main Takeaways:
- The protein Raptor has genetic connections to lifespan and aging.
- Understanding the role of Raptor could provide insights into the biological mechanisms of aging.
Notes: Part of a discussion on protein complexes and aging
Tone: Informative
Relevance: 4/5
“mtor lived at this very interesting interface where the cell produces its own nutrients by breaking down things and also where the nutrients are coming in from the outside”
Main Takeaways:
- mTOR is located at a key site in cells where internal nutrient production and external nutrient absorption intersect.
- This positioning of mTOR suggests its significant role in managing cellular nutrition and metabolism.
Notes: Explaining the function and location of mTOR in cells
Tone: Explanatory
Relevance: 5/5
“the catalic Inhibitors basically annihilate the activity of mtor 1 and Mt 2 if used at the right dose rapy partially inhibits mtor 1 and over time can also partially inhibit mtor 2”
Main Takeaways:
- Catalytic inhibitors can completely inhibit the activity of both mTOR 1 and mTOR 2 at the correct dosage.
- Rapamycin partially inhibits mTOR 1 and, with prolonged use, can also inhibit mTOR 2.
Tone: Informative
Relevance: 5/5
“if I use rap for a long period of time I inhibit akt and I also break apart mtor 2”
Main Takeaways:
- Long-term use of rapamycin can inhibit AKT and disrupt mTOR 2.
Notes: Discussion on the effects of prolonged rapamycin use.
Tone: Cautious
Relevance: 5/5
“the assumption that the reason rapy is extending lifespan and affecting healthspan metrics is purely because of the M torque one inhibition and I would say that piece we don't completely know”
Main Takeaways:
- Rapamycin is assumed to extend lifespan and improve healthspan metrics primarily through mTORC1 inhibition.
- The complete mechanisms by which rapamycin affects aging are still not fully understood.
Notes: Discussion on the effects of rapamycin on aging
Tone: Cautious
Relevance: 4/5
“the best evidence for the idea that the benefits of Ramy and come from mtor 1 inhibition is the genetic data which we've sort of alluded to in yeast and worms and flies and mice where you can mutate proteins or genes that code for proteins in mtor complex one and see lifespan and health span benefits”
Main Takeaways:
- Genetic studies in yeast, worms, flies, and mice suggest that mutating genes associated with mTORC1 can extend lifespan and improve healthspan.
- These findings support the hypothesis that mTORC1 inhibition is a key mechanism behind the benefits of rapamycin.
Notes: Discussion on genetic studies supporting mTORC1's role in aging
Tone: Neutral
Relevance: 5/5
“I'm not convinced at this point that the idea that all of the benefits are due to M torque 1 inhibition and all of the side effects are due to mtor 2 inhibition”
Main Takeaways:
- The speaker expresses skepticism about the model that separates the benefits and side effects of rapamycin into mTORC1 and mTORC2 inhibition respectively.
- This indicates a need for further research to accurately understand rapamycin's mechanisms.
Notes: Expressing doubt about the current understanding of rapamycin's effects
Tone: Skeptical
Relevance: 4/5
“Tim did a simple experiment he said well let me remove amino acids and look where mtor is and it turned out it wasn't on lomes anymore it went off the lome then he added amino acids and he had even little movies within minutes it went back to the lomes.”
Main Takeaways:
- Removing amino acids caused mTOR to move away from lomes.
- Reintroducing amino acids caused mTOR to return to lomes quickly.
- This experiment demonstrated the dynamic response of mTOR to nutrient availability.
Notes: Describing a laboratory experiment
Tone: Informative
Relevance: 5/5
“Joe avick he had a paper in JBC where he looked at amino acid regulation of mtor this was this is before the lomes he was looking at the activity of using S6 kyes and he basically found a couple amino acids that mattered he found Lucine you know a very common essential Branch chain amino acid an important component of of whey protein for example that people take Arginine a very basic amino acid technically not essential lots of nitrogen in in that amino acid and those were the two big ones that he found.”
Main Takeaways:
- Joe Avick's research identified specific amino acids, Lucine and Arginine, as significant in the regulation of mTOR.
- Lucine is an essential branched-chain amino acid, commonly found in whey protein.
- Arginine, although not essential, is noted for its high nitrogen content.
Notes: Discussing historical research findings
Tone: Informative
Relevance: 5/5
“the Holy Grail was how is Lucine detected that was the thing we wanted to know literally for decades and the reason was is that there's a lot of literature in mice in humans in big animals um you know used in farms that Lucine does cool stuff like boost satiety you know feeling of of having fed boost muscle mass and eventually we found it we found the receptor for Lucine it's a protein called sestrin.”
Main Takeaways:
- Lucine has been extensively studied for its effects on satiety and muscle mass across various species.
- The receptor for Lucine, identified as sestrin, plays a crucial role in its detection and subsequent biological effects.
Notes: Explaining the significance of discovering Lucine's receptor
Tone: Enthusiastic
Relevance: 5/5
“the immediate idea was hey can we mimic the anabolic effects of Lucine without taking Lucine can we make something better than Lucine and and we've managed to make things slightly better but nothing dramatically better and the structure tells you why because it's it basically is made to fit Lucine and nothing else”
Main Takeaways:
- Research aims to mimic the anabolic effects of Lucine without directly consuming it.
- Attempts to improve upon Lucine have yielded only slight enhancements.
- The molecular structure of Lucine is unique, making it difficult to replicate or improve significantly.
Notes: Discussion on amino acids and their structural specificity
Tone: Explanatory
Relevance: 4/5
“that mtor is the most important sensor we have not just for nutrients but perhaps more importantly the most critical nutrients of them all which are amino acids”
Main Takeaways:
- mTOR acts as a critical sensor for nutrients, especially amino acids.
- Amino acids are highlighted as particularly vital nutrients.
Notes: Discussion on the role of mTOR in nutrient sensing
Tone: Informative
Relevance: 5/5
“sarcopenia is an enormous risk to both lifespan and healthspan sarcopenia meaning low muscle mass”
Main Takeaways:
- Sarcopenia, or low muscle mass, poses a significant risk to both lifespan and healthspan.
- Maintaining muscle mass is crucial for longevity and overall health.
Notes: Explanation of sarcopenia and its impacts on health
Tone: Concerned
Relevance: 5/5
“you need mtor activation to build new muscle um and so the idea was that rapamycin treatment inhibiting mtor turning down mtor should lead to faster muscle loss that was the prediction that was made so that rapamycin should induce sarcopenia if you were to treat animals with rapamycin as they were getting older that would that was the prediction that was made the reality turns out to be the opposite”
Main Takeaways:
- mTOR activation is necessary for muscle building.
- Rapamycin, which inhibits mTOR, was predicted to accelerate muscle loss and induce sarcopenia.
- Contrary to predictions, rapamycin treatment in animal studies has shown to preserve muscle mass in aging.
Notes: Discussion on the effects of rapamycin on muscle mass and mTOR inhibition
Tone: Surprised
Relevance: 5/5
“I'm talking more about the studies of protein restriction and Branch chain amino acid restriction which in mice seem to have some positive effects on longevity but because mice are not they don't develop sarcopenia to the same extent or in the same way that people do I would worry a bit about extrapolating from that to say that it's going to have those same beneficial effects in people where sarcopenia seems to be much more important for quality of life probably life expectancy but certainly quality of life in in older adults.”
Main Takeaways:
- Protein and branch chain amino acid restriction have shown positive effects on longevity in mice.
- Mice do not develop sarcopenia like humans, making direct extrapolation to humans questionable.
- Sarcopenia in humans significantly impacts quality of life and potentially life expectancy.
Notes: Discussion on the relevance of animal model studies to human health outcomes.
Tone: Cautious
Relevance: 4/5
“Veronica galvin's done some stuff for dementia brain aging um I don't know about lifespan I think and finle may have done something but I I but but in general it has not been done outside of you know if it's been done there was like a adapost specific knock down knockout I and uh maybe liver specific but certainly not systematically looking across different tissues right.”
Main Takeaways:
- Research on specific tissue impacts on lifespan and healthspan is limited.
- Some studies have focused on specific tissues like adipose or liver, but not systematically across various tissues.
- Veronica Galvin has conducted research related to dementia and brain aging.
Notes: Discussion on the complexity of aging research and its focus on specific tissues.
Tone: Neutral
Relevance: 4/5
“I think this brain penetration question again as David I think correctly noted there's disagreements out there about how effectively does Romy cross the blood brain barrier how how much rapamycin do you need to get inhibition of M torque 1 in the brain what I can tell you from our own studies is certainly at higher Doses and I think this matches what what you've seen David is that we see potent inhibition of mtor complex one in the brain after repeated dosing at higher doses where we're using IP injection we haven't really compared this to lower doses where the rapamycin is in the food.”
Main Takeaways:
- There is debate about how effectively rapamycin crosses the blood-brain barrier.
- Higher doses of rapamycin have shown potent inhibition of mTOR complex 1 in the brain in studies.
- The effect of lower doses of rapamycin, especially when administered in food, is less clear.
Notes: Discussion on the challenges of drug delivery to the brain and the effectiveness of rapamycin in inhibiting mTOR in brain tissues.
Tone: Cautious
Relevance: 4/5
“obviously in patients who are high risk for Alzheimer's disease if they're in a clinical trial you might be able to justify amalo pet or lumbar punctures to look for amalo in the cerebral spinal fluid but not only does that come with the case of you know a lot of radiation and potential morbidity respectively for those procedures it's simply not practical if you're you know uh clinically practicing medicine”
Main Takeaways:
- Invasive procedures like amalo PET scans or lumbar punctures are used in clinical trials for high-risk Alzheimer's patients to detect amyloid in the cerebral spinal fluid.
- These procedures involve significant radiation and potential morbidity, making them impractical for routine clinical practice.
Tone: Cautious
Relevance: 5/5
“this c2n assay which was approved a couple of years ago has become a really important part of how we manage risk in our high-risk patients”
Main Takeaways:
- The C2N assay, approved recently, is crucial for managing risk in patients at high risk for Alzheimer's disease.
- It measures amyloid levels non-invasively, offering a practical alternative to more invasive tests.
Tone: Informative
Relevance: 5/5
“for our very high-risk patients who are showing amalloy already in the plasma um I believe we have put two of them on intermittent Romy so anywhere from 5 to 8 milligrams once a week and in both cases the C 2 end score has improved meaning uh you know every 3 months when we are checking the amalloy concentration it's going down”
Main Takeaways:
- Intermittent dosing of Romy (5 to 8 mg weekly) has been used in high-risk Alzheimer's patients with detectable amyloid in plasma.
- This treatment has led to improvements in C2N scores, indicating a reduction in amyloid levels.
Tone: Optimistic
Relevance: 5/5
“you could treat with Rapa for I think six weeks in that study um and rejuvenate the immune function of a mouse and to me the one experiment in there that is most most compelling is they they have a set of mice I think they were 24 months of age when they started this experiment and then they had young mice and the mice got um either a flu vaccine or no vaccine and then they waited and then they gave them what would be a lethal dose of influenza if they hadn't been vaccinated and then in the Aged mice they either got rap a in for six weeks or they didn't and so if you're a young Mouse and you don't get a vaccine and you get this dose of influenza there's 100% mortality within I think it was 8 days days that makes sense right no vaccine you're not protected against the influenza if you're a young mouse that got the vaccine 100% protection so that again makes sense it's a control if you're an old mouse No rrap a you get a vaccine only 30% of the mice actually were protected so this is showing…”
Main Takeaways:
- Rapamycin treatment for six weeks rejuvenated immune function in aged mice.
- Aged mice treated with rapamycin showed a 100% survival rate against a lethal dose of influenza post-vaccination.
- This study suggests potential for immune rejuvenation treatments in aged populations.
Notes: Discussing a mouse study on immune rejuvenation
Tone: Enthusiastic
Relevance: 5/5
“it might be in fact it very likely is the case that you can also suppress the immune system interestingly these are the same parts of the immune system that is there to fight a virus that is also there to reject an organ”
Main Takeaways:
- Suppression of the immune system can affect its ability to fight viruses and reject transplanted organs.
- The immune system is complex and involves various components, including T cells and cellular immune systems.
Notes: Discussion on immune system complexity and function
Tone: Informative
Relevance: 4/5
“the people who take immunosuppressant chronically have higher rates of certain types of cancer which of course makes sense”
Main Takeaways:
- Chronic use of immunosuppressants is linked to increased rates of certain cancers.
- Immunosuppressants can have significant long-term health risks.
Notes: Discussion on the side effects of long-term immunosuppressant use
Tone: Cautious
Relevance: 4/5
“if you could look at the epigenome of the te- cells in those patients in the manic clickin study do you believe that you would see a change in the methylation pattern pre and post Ramy”
Main Takeaways:
- Epigenetic changes, specifically methylation patterns, in T cells could potentially be influenced by treatments.
- The study mentioned explores the impact of a treatment on the epigenome of T cells.
Notes: Hypothetical discussion on potential changes in the epigenome due to treatment
Tone: Inquisitive
Relevance: 4/5
“in six weeks which is nothing in this in this in this span of a person's lifetime six weeks of inhibiting mtor and again let's do it in the mouse experiment because that's so much more dramatic right and now admittedly six weeks might be analogous to you know a year year or so in a human's life but in a relatively short period of time you have a log function change in the immune system of the older Mouse”
Main Takeaways:
- Short-term inhibition of mTOR in mice shows dramatic changes in the immune system.
- Six weeks in a mouse's life may be analogous to about a year in a human's life.
- This suggests potential for significant disease prevention or immune system rejuvenation in a relatively short period.
Notes: Discussing the impact of mTOR inhibition on aging mice's immune systems.
Tone: Analytical
Relevance: 4/5
“6 weeks of Romy is enough to knock down chronic sterile inflammation to the point where you have a resetting of immune function which then allows the immune system to appropriately respond in a way that functionally is like a young immune system to a vaccine”
Main Takeaways:
- Short-term treatment with rapamycin can reduce chronic inflammation and reset immune function.
- This treatment makes the immune system of older individuals respond similarly to that of younger individuals.
- Suggests potential for improving vaccine efficacy and overall immune response in older adults.
Notes: Discussing the effects of rapamycin on immune function and inflammation in the context of aging.
Tone: Optimistic
Relevance: 5/5
“it just means that there is no indication for its use and and you compared them to a group of people you tried your best to match uh nearly 200 if I recall who were you know hopefully as similar as possible in terms of their health Consciousness which would be an obvious confounder uh but who were not rapy users”
Main Takeaways:
- The study compared rapy users with a control group of nearly 200 non-users.
- Both groups were matched for health consciousness to minimize confounding variables.
- The use of rapy was off-label, meaning it was not officially approved for the conditions being treated.
Notes: Discussion about a study comparing rapy users and non-users.
Tone: Neutral
Relevance: 4/5
“there really was no evidence when you look between the people who were using rapy off label and the people who' never used rapy for significant side effects of of any sense other than mouth sores”
Main Takeaways:
- No significant side effects were found in the study between rapy users and non-users, except for mouth sores.
- Mouth sores were statistically more common among rapy users.
Notes: Highlighting the primary findings from a study on off-label rapy use.
Tone: Neutral
Relevance: 4/5
“why don't people do fk506 mouthwashes I don't get this right cuz all you need to do is occupy Stuart shriber showed this I don't know ages ago right if you occupy the FK the r the fkbp with fk506 Romy has nothing to act on in your mouth and you'll prevent this because as far as I know fk6 does not do this”
Main Takeaways:
- Suggests using fk506 mouthwashes to prevent mouth sores caused by rapy.
- The mechanism involves occupying binding sites in the mouth, preventing rapy from acting there.
Notes: Proposing a preventative measure for a common side effect of rapy.
Tone: Inquisitive
Relevance: 4/5
“whether wrap a mice in toothpaste or wrap a mice in mouthwash or something like that specifically delivered to the oral Cav it is that sufficient to get some of the benefits that we've shown in mice from systemic Rapa and treatment on periodon disease gingival inflammation bone growth around the teeth”
Main Takeaways:
- Exploring localized delivery of rapamycin in oral care products like toothpaste or mouthwash.
- Potential benefits include treatment of periodontal disease, gingival inflammation, and promoting bone growth around teeth.
- This approach aims to leverage systemic benefits of rapamycin specifically for oral health.
Notes: Discussion on experimental approaches in oral health
Tone: Inquisitive
Relevance: 4/5
“depression and anxiety and there's a whole growing body of literature on the role of mtor and inhibition of mtor in various types of neurocognitive behavioral um uh aspects and so it makes me wonder if that actually might be real that that to some extent in some people Romy could actually have some what in this case appear to be beneficial effects on things like depression and anxiety”
Main Takeaways:
- Discussion on the potential beneficial effects of mTOR inhibition on depression and anxiety.
- Suggests that rapamycin might have positive effects on mental health for some individuals.
- Highlights the need for further research into the neurocognitive and behavioral impacts of mTOR inhibitors.
Notes: Exploration of mTOR's role in mental health
Tone: Speculative
Relevance: 4/5
“First of all, no difference in frequency of infection that was significant, so there's no reason to believe based on our data that rapamycin impacted the likelihood that somebody would get a positive COVID-19 result.”
Main Takeaways:
- Rapamycin did not significantly affect the likelihood of contracting COVID-19.
- The study was based on self-reported data without laboratory confirmation.
- No significant difference in infection rates between rapamycin users and non-users.
Notes: Discussing the impact of rapamycin on COVID-19 infection rates.
Tone: Neutral
Relevance: 4/5
“Big difference, at least statistically significant, between people who took rapamycin throughout and all of the other groups where people who took rapamycin throughout had lower severity of infection and statistically significantly less likelihood of reporting symptoms associated with long COVID.”
Main Takeaways:
- Continuous use of rapamycin during COVID-19 infection may reduce severity and long COVID symptoms.
- Statistically significant findings suggest a potential benefit of rapamycin in managing COVID-19.
- Further research is suggested to explore rapamycin's effects on COVID-19.
Notes: Analysis of different usage patterns of rapamycin among COVID-19 patients.
Tone: Cautious
Relevance: 5/5
“if you give a cic inhibitor to a mouse you can actually kill a mouse fairly easily”
Main Takeaways:
- CIC inhibitors can be lethal to mice.
- Indicates high toxicity of CIC inhibitors in small doses.
Notes: Discussing the effects of substances on mice
Tone: Cautious
Relevance: 4/5
“a catalic inhibitor which is basically a molecule that will compete with ATP which is what mtor uses to do all its business that will literate mtor 1 and M torque 2 activity certainly when given at the right Doses”
Main Takeaways:
- Catalytic inhibitors compete with ATP to affect mTOR activity.
- Can inhibit both mTORC1 and mTORC2 when dosed correctly.
Notes: Explaining how catalytic inhibitors function
Tone: Informative
Relevance: 5/5
“with diet you can get close to uh to rap ayon's uh impact and and again this is my my personal belief with with some some has supported but what I know you can't get close to with diet is what a catalytic inhibitor can do”
Main Takeaways:
- Diet can somewhat mimic the effects of rapamycin on mTOR inhibition.
- Diet cannot achieve the same effects as catalytic inhibitors.
Notes: Comparing dietary impact to substances on mTOR
Tone: Speculative
Relevance: 4/5
“the molecules that we use these very hyp specific ones and they are bad news for for an animal when when you”
Main Takeaways:
- Specific molecules discussed are highly specific inhibitors.
- These inhibitors are implied to have negative effects on animals.
Notes: Discussion on the specificity and effects of certain molecular inhibitors
Tone: Cautious
Relevance: 3/5
“I would love to see somebody take a panel of all of the no and mtor Inhibitors in these different classes and just ask the question if you look in an animal model what's the relative benefit and side effect profile look like in the context of longevity”
Main Takeaways:
- Interest in studying the effects of mTOR inhibitors on longevity.
- Suggestion to compare different classes of mTOR inhibitors in animal models.
Notes: Exploration of potential research in longevity and mTOR inhibitors
Tone: Inquisitive
Relevance: 4/5
“the catalic Inhibitors are actually very challenging to use they're very hydrophobic molecules because the catalytic site of Emptor is like a very hydrophobic site so everyone who independently made these molecules ended up with very greasy molecules that are not easy to dose in in a mouse very hard to dose”
Main Takeaways:
- Catalytic inhibitors are difficult to use due to their hydrophobic nature.
- These inhibitors are challenging to administer in mouse models due to their 'greasy' molecular structure.
Notes: Discussion on the physical properties of catalytic inhibitors and their implications for research
Tone: Challenging
Relevance: 4/5
“in those patients who got the rtb 101 there was a significantly lower risk of subsequent infection for certain viruses among them influenza viruses and Corona viruses not covid-19 because we didn't know about covid-19 when this was happening but Corona viruses as a class the people who'd gotten rtb 101 showed a significantly lower likelihood of a future laboratory confirmed viral infection”
Main Takeaways:
- RTB 101 was associated with a reduced risk of viral infections, including influenza and other coronaviruses.
- The study did not include COVID-19 as it was conducted before the pandemic.
- The findings suggest potential antiviral benefits of RTB 101.
Notes: Discussion on the outcomes of a clinical trial involving RTB 101.
Tone: Neutral
Relevance: 5/5
“whether that trial was actually a failure it was a failure in the sense that they didn't get to FDA approval and they shut it down early whether it was actually a failure of the drug I think Still Remains TBD”
Main Takeaways:
- The clinical trial for RTB 101 was terminated early and did not achieve FDA approval.
- The effectiveness of RTB 101 in preventing disease remains uncertain.
Notes: Reflecting on the discontinuation of the RTB 101 trial.
Tone: Cautious
Relevance: 4/5
“then they looked at Downstream Pathways genetically and found the biggest impact of perturbing uh autophagy part of it is based on common sense you know it it breaks down old things and allows their Rejuvenation”
Main Takeaways:
- Research has explored genetic pathways affecting autophagy.
- Autophagy is crucial for breaking down old cellular components and promoting cellular rejuvenation.
- Genetic perturbation can significantly impact autophagy.
Notes: Discussion on genetic research related to aging
Tone: Explanatory
Relevance: 4/5
“I think to some extent we almost can't ask the question what is important Downstream of mtor because the answer is that mtor is special because it does a lot of things and therefore we can't find one thing that replicates Amur otherwise we would have already found those things right”
Main Takeaways:
- mTOR is a complex protein that influences multiple downstream processes.
- It's challenging to isolate a single most important effect of mTOR due to its wide-ranging impact.
- The complexity of mTOR's role makes it a critical focus in aging research.
Notes: Discussion on the complexity of mTOR in genetic pathways
Tone: Analytical
Relevance: 4/5
“I think the real answer is to why mtor and thus Rapa are special is that mtor does a lot of stuff and to impact the aging process you have to do a lot of stuff”
Main Takeaways:
- mTOR's extensive role in cellular processes makes it a key target in aging research.
- Rapamycin (Rapa) is highlighted as significant due to its interaction with mTOR.
- Addressing aging effectively requires influencing multiple cellular mechanisms.
Notes: Explaining the significance of mTOR and Rapamycin in aging
Tone: Informative
Relevance: 5/5
“the dogs have to be at least 7 years old at the time of randomization and they can't be sick, they can't have any significant pre-existing age related disease.”
Main Takeaways:
- The study focuses on normative aging, not disease-specific interventions.
- Participants (dogs) must be free of significant pre-existing age-related diseases to qualify.
- The study aims to understand the effects of interventions on healthy aging subjects.
Notes: Discussing the criteria for participation in a clinical trial on aging in dogs.
Tone: Informative
Relevance: 5/5
“we're looking at multiple measures of Health span including cardiac function, neurological function, activity, cognitive function.”
Main Takeaways:
- The study measures various aspects of health span, including physical and cognitive functions.
- Activity levels are monitored as part of the health span metrics.
- The comprehensive approach helps understand the overall impact of the intervention on health.
Notes: Details on the health metrics assessed in the clinical trial for aging dogs.
Tone: Detailed
Relevance: 4/5
“we can actually design a clinical trial and this is a real clinical trial double blind randomized Placebo controlled Veterinary clinical trial to answer the question does rap ayon slow aging increase lifespan improve multiple healthspan metrics in a reasonable time frame.”
Main Takeaways:
- The trial is designed to rigorously test the effects of a substance on aging and metabolic health.
- It is a double-blind, randomized, placebo-controlled trial, ensuring the reliability of the results.
- The focus is on both lifespan and various healthspan metrics.
Notes: Explaining the structure and purpose of the clinical trial involving dogs.
Tone: Scientific
Relevance: 5/5
“I'm not sure that lifespan so even though we're powered for lifespan that's our primary Endo I'm honestly not sure that's the most important end point for evaluating potential efficacy of rapy in in dogs or people right I mean I think we want to think about this more broadly speaking in the sense that there may be some health span metrics that are particularly and potently positively impacted by people just also want to make sure there's no negative lifespan though that's the thing too.”
Main Takeaways:
- Lifespan may not be the most crucial metric for evaluating the efficacy of rapamycin in dogs or humans.
- Health span improvements are also significant metrics to consider.
- It's essential to ensure that treatments do not negatively impact lifespan.
Notes: Discussion on the importance of health span versus lifespan in clinical studies
Tone: Cautious
Relevance: 4/5
“I would be shocked if we see a shortening of lifespan from Rapa mice and treatment just given everything that I know to this point in mice and the data we've gotten so far in dogs.”
Main Takeaways:
- The speaker expects no reduction in lifespan from rapamycin treatment based on existing data from mice and dogs.
- Confidence is expressed based on prior studies and observations.
Notes: Expressing expectations based on previous research outcomes
Tone: Confident
Relevance: 4/5
“Rapa may be having positive survival effects in marma sets so again I think if that pans out and we actually see a statistically significant Improvement in lifespan from marac sets that's really important because now it's gotten to the point of a primate right which we don't have data for yet obviously closer to humans.”
Main Takeaways:
- Preliminary results suggest rapamycin may improve survival in marmosets.
- Significant because it extends findings to primates, which are closer to humans in biological terms.
Notes: Discussing ongoing research and its implications for primate studies
Tone: Optimistic
Relevance: 4/5
“once weekly dosing with everolimus seemed to give similar efficacy with maybe lower potential side effect risk”
Main Takeaways:
- Weekly dosing of everolimus may be as effective as more frequent dosing.
- Weekly dosing could potentially have fewer side effects.
- This dosing schedule might be easier for pet owners to manage.
Notes: Discussion about dosing frequency in a veterinary context
Tone: cautious
Relevance: 4/5
“our dose is too low we all have to go low because you're trying to weigh risk reward right and in people's pets risk is the tolerance for risk is extremely low”
Main Takeaways:
- The dosing in the study is intentionally low to minimize risk, considering the low tolerance for risk in treating pets.
- Concerns exist that the low dosing may not achieve statistically significant effects.
Notes: Discussion on balancing dosing efficacy with risk in veterinary studies
Tone: concerned
Relevance: 4/5
“the mice were actually given 1.4 milligrams per kilogram per day in the ITP which works out to when you convert that to human dosing which is the there's a conversion factor it works out to 0.1 migs per kilogram per day is what they were getting if they were humans”
Main Takeaways:
- Mice in the ITP study were given 1.4 mg/kg/day.
- Converted to human dosing, this equates to 0.1 mg/kg/day.
Notes: Discussion on dosing conversion from animal models to humans
Tone: informative
Relevance: 5/5
“A lot of these are n of one experiments with people who are changing their regimens as they go so there are some people who are taking you know six milligrams once a week but they're trying to build it up to some higher dose to see where they start to get side effects.”
Main Takeaways:
- Individuals are self-experimenting with varying doses of substances to observe effects.
- The goal is to determine personal tolerance and side effects.
Tone: Neutral
Relevance: 4/5
“There are a bunch of people who reported taking grapefruit juice with their rapamycin because grapefruit juice will inhibit cytochrome p450s and enhance bioavailability of rapamycin.”
Main Takeaways:
- Grapefruit juice is used to inhibit cytochrome p450 enzymes, enhancing the bioavailability of rapamycin.
- This practice is part of self-experimentation to potentially increase the effectiveness of the drug.
Tone: Neutral
Relevance: 4/5
“I would caution people against using any compounded formulations here. Yes, they'll make it a lot cheaper but you have virtually no guarantee of the purity or the concentration.”
Main Takeaways:
- Compounded formulations of drugs may be cheaper but lack guaranteed purity and concentration.
- Using such formulations involves significant risks due to quality control issues.
Tone: Cautious
Relevance: 5/5
“Rapamycin is unstable at gastric pH and so if compounded rapamycin is not in an enteric coated capsule you're essentially going to get zero bioavailability.”
Main Takeaways:
- Rapamycin's stability is compromised by gastric pH, requiring protective formulation.
- Enteric coated capsules are necessary to ensure rapamycin's bioavailability when ingested.
Tone: Cautious
Relevance: 5/5
“I don't know that that's been even carefully done has anybody looked at rapamycin Administration and antimullerian hormone level for example um you know once let's say a woman is already in her AMH decline but hasn't fully bottomed out to zero could you rescue some of that.”
Main Takeaways:
- Rapamycin administration may impact antimullerian hormone (AMH) levels, which are indicative of a woman's ovarian reserve.
- The potential for rapamycin to rescue declining AMH levels in women is being questioned.
- AMH levels typically decrease as women age, impacting fertility.
Notes: Discussion on the potential effects of rapamycin on hormone levels in women.
Tone: Inquisitive
Relevance: 4/5
“if you look at the physiology of that it is is a monotonically decreasing function and it is very Steep and if you could simply stop it from declining that would be remarkable let alone turn it in the other direction.”
Main Takeaways:
- The speaker discusses the steep and consistent decline of AMH levels in women.
- Stopping or reversing this decline would be considered a significant achievement.
Notes: Theoretical discussion on altering the natural decline of hormone levels.
Tone: Optimistic
Relevance: 4/5
“the impetus grants Foundation funded that trial they're also funding a periodontal disease trial out of the University of Washington.”
Main Takeaways:
- The Impetus Grants Foundation is funding a clinical trial focused on periodontal disease.
- This trial is being conducted at the University of Washington.
Notes: Mention of a funded trial aiming to prevent or treat periodontal disease.
Tone: Informative
Relevance: 3/5
“it's very clear that the nutrient sensing the response to nutrient deprivation is not just mtor at all in fact the nutrient sensors we found clearly talk to a whole bunch of other processes”
Main Takeaways:
- Nutrient sensing involves more than just the mTOR pathway.
- Nutrient deprivation triggers responses across multiple biological processes.
- Understanding nutrient sensing can provide insights into cellular and metabolic health.
Notes: Discussion on nutrient sensing and deprivation
Tone: Informative
Relevance: 4/5
No comments yet.